Pure-play Cannabis Stock Insights from Lorimer Wilson

This article highlights ten insightful cannabis articles written by Lorimer Wilson

Written by Lorimer Wilson, editor of munKNEE.com

What do you really know about the cannabis stock market? Not much I would expect, as little of substance is being written about the cannabis stock market these days other than articles hyping/promoting specific client companies. That short-coming has just come to an end. This post highlights the extremely insightful daily articles he posts exclusively on TalkMarkets.com. Check them out.

  1. Cannabis Central: 92% Of Pot Stock Index Constituents Advanced Friday

The Pot Stock Index of the 25 pure-play cannabis stocks that trade for +US$1/share advanced 3.7% on Friday with 23 of the constituents advancing.

  1. “Marijuana” ETFs: A Troubling Expose

A look at the constituent makeup of the 11 publicly traded “marijuana” ETFs reveals that they include a large percentage of pharmaceutical, real estate, grower supply, and tobacco/spirit companies. Why is that? Here’s the surprising reason.

  1. Cannabis Central: Pure-Play Pot Stock Index Reversed Last Week

Our Pot Stock Index continues to flip-flop weekly. This past week was no exception with the index up 6.3% vs. being down 9.2% the previous week and up 10.0% the week before that.

  1. Cannabis Central: Cresco Labs’ Q2 Financial Results Were Outstanding

Cresco Labs - logoCresco Labs Inc., a vertically integrated multi-state cannabis operator in the United States, today released its unaudited financial results for the second quarter ended June 30, 2020 and, as can be seen below, they were outstanding across the board.

  1. Cannabis Central: American MSOs Have Dramatically Outperformed Canadian LPs Year-To-Date

The pure-play Pot Stock Index is down 15.0% YTD but the American Multi-State Operators (MSOs) category within the index is up 11.9% compared to the Canadian Licensed Producers (LPs) category which is down 38.1% since the beginning of 2020.

  1. Cannabis Central: These 8 Pot Stocks Have Gone Down 40% To 60% YTD

Of the 300 cannabis stocks that actively trade on the various Canadian and American stock exchanges only 25 are pure-play cannabis companies who derive 100% of their revenue from the sale of cannabis or cannabis-related products.

  1. Cannabis Central: Pot Stocks Are DOWN 20% YTD But These 11 Are UP 36% YTD

Cannabis stocks are DOWN 20%, on average, YTD but there are 11 stocks in munKNEE.com’s Pot Stock Index that are UP 35.8%, on average, YTD. This article identifies these hidden gems and how well they have done over the past 7 months.

  1. Cannabis Central: What A Difference A Month Makes

Our Pot Stock Index was up +16.5% in July compared to a -8.0% decline in June. Here are July’s major winners and losers.

  1. Cannabis Central: A Conservative Approach To Investing In The Marijuana Industry

Seven major consumer and pharmaceutical corporations have bought into marijuana companies to take full advantage of this rapidly growing market.

  1. These 7 Indexes Track The Performance Of Pot Stocks – Which Are The Best & Why?

The marijuana market consists of 313 companies from which various numbers of them are included in seven indexes. Which ones are the best?

//

munKNEE.com is a new affiliate of eResearch.com. To learn more about munKNEE.com, please visit their website and sign-up for their weekly newsletter.

To view the original article and more from munKNEE.com, please visit: https://www.munknee.com/cannabis-central-dont-buy-a-pot-stock-without-reading-this-article/

 //

About Chris Thompson 352 Articles
Chris Thompson is the President and Director of Equity Research at eResearch. He is a Professional Engineer and CFA Charterholder with a MBA in Investment Management and over 15 years of experience in software development, FinTech, telecommunications, and information technology. For the past 10 years, he has worked in the Capital Markets in Equity Research, M&A Investment Banking and Consulting in various sectors.